Bisphosphonates Enhance the Expression of Dental Matrix Protein 1 
in the Mandibular Alveolar Bone of Ovariectomized Rats

doi:10.3969/j.issn.1005-4979.2016.02.003

Abstract

Abstract: Objective: To examine the effects of bisphosphonates on the expression of dentin matrix protein 1 (DMP1) and osteoclasts in the mandibular alveolar bone of ovariectomized osteoporosis rats. Methods: Female Sprague-Dawley rats aged 6 months (total=30) were randomly divided into three groups. Sham group (n=10) underwent sham operation only. OVX group (n=10) received a bilateral ovariectomy first and then injection of sterile saline subcutaneously for 3 months. RIS group (n=10) also received a bilateral ovariectomy and underwent risedronate treatment （2.4μg/kg） subcutaneously for 3 months. Three months after the operation, all animals were sacrificed. Toluidine blue staining was performed to examine the structure changes of first molar teeth (M1) alveolar bone. The number of osteoclasts in M1 alveolar bone was evaluated by tartrate-resistant acid phosphatase (TRAP) staining. To detect DMP1 protein in alveolar bone sections, immunohistochemical analysis was performed, and then by hemi-quantitative imaging analysis. Results: The results of TRAP staining indicated that the number of osteoclasts was significantly greater in OVX group than the Sham group (P<0.05), while the number at RIS group was lower than OVX group (P<0.05). Immunohistochemistry staining showed that DMP1 localized mainly in osteocytes of alveolar bone, trabecular bone matrix and periodontal ligament. The expression levels of DMP1 proteins statistically decreased in OVX group than Sham group (P<0.05), and DMP1 increased in RIS group than OVX group. Conclusion: Bisphosphonates inhibit alveolar bone resorption via reducing the number of osteoclasts, and meanwhile increase the expression of DMP1, which can influence mandibular alveolar bone biomineralization.

Key words: bisphosphonate, osteoporosis, ovariectomy, mandibular alveolar bone, dentin matrix protein 1

摘要： 目的：观察二膦酸盐对去卵巢骨质疏松大鼠下颌牙槽骨内破骨细胞以及牙本质基质蛋白1（dentin matrix protein1，DMP1）表达的影响。方法：取6月龄SD大鼠30只，随机分为假手术组（Sham)、去卵巢模型组（OVX）和二膦酸盐药物治疗组（RIS），每组10只。Sham组大鼠仅术中暴露卵巢不切除，OVX组大鼠行“双侧卵巢切除术+生理盐水皮下注射”，RIS组行“双侧卵巢切除术+利塞磷酸钠（2.4μg/kg）皮下注射”。术后3个月取各组大鼠下颌骨常规脱钙，甲苯胺兰染色观察下颌第一磨牙（M1）区域牙槽骨组织学结构，抗酒石酸酸性磷酸酶(tartrate?鄄resistant acid phosphatase，TRAP)染色观察M1区域牙槽纵隔破骨细胞的骨吸收情况，免疫组化染色观察各组M1牙槽骨DMP1分布表达情况，并进行相关半定量图像分析。结果：与Sham组相比，OVX组TRAP阳性细胞数增加；而较OVX组而言，RIS组TRAP阳性细胞数显著减少（P<0.05）。免疫组化染色显示，各组DMP1不仅表达在牙槽骨骨细胞内，牙槽间隔的松质骨骨基质、牙周韧带中均可见其表达，OVX组M1牙槽骨DMP1表达较Sham组减少（P<0.05），而RIS组表达较OVX组有升高。结论: 二膦酸盐能减少骨质疏松大鼠下颌牙槽骨破骨细胞数量，并上调DMP1表达，从而影响下颌牙槽骨矿化。

关键词: 二膦酸盐, , , 骨质疏松, , , 去卵巢, , , 下颌骨牙槽骨, , , 牙本质基质蛋白1

CLC Number:

R782.13

JIANG Li-ting, ZHOU Qi, WEI Li，LI Ning，GAO Yi-ming. Bisphosphonates Enhance the Expression of Dental Matrix Protein 1
in the Mandibular Alveolar Bone of Ovariectomized Rats[J]. 《Journal of Oral and Maxillofacial Surgery》, 2016, 26(2): 88-95.

江莉婷，周琦，魏立，李宁，高益鸣. 二膦酸盐对骨质疏松大鼠下颌牙槽骨牙本质基质蛋白1表达的影响[J]. 《口腔颌面外科杂志》, 2016, 26(2): 88-95.

/ / Recommend / Download Citations

URL: https://journal06.magtech.org.cn/Jweb_joms/EN/10.3969/j.issn.1005-4979.2016.02.003

https://journal06.magtech.org.cn/Jweb_joms/EN/Y2016/V26/I2/88

References

[1] Xu XL, Gou WL, Wang AY, et al. Basic research and clinical applications of bisphosphonates in bone disease: what have we learned over the last 40 years[J]？ J Transl Med, 2013, 11:303.

[2] Gerstenfeld LC, Sacks DJ, Pelis M, et al. Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing[J]. J Bone Miner Res, 2009, 24(2):196-208.

[3] Allen MR. The effects of bisphosphonates on jaw bone remodeling, tissue properties, and extraction healing[J]. Odontology, 2011, 99(1):8-17.

[4] Batra N, Kar R, Jiang JX. Gap junctions and hemichannels in signal transmission, function and development of bone[J]. Biochim Biophys Acta, 2012, 1818(8):1909-1918.

[5] Schaffler MB, Cheung WY, Majeska R, et al. Osteocytes: master orchestrators of bone[J]. Calcif Tissue Int, 2014, 94(1):5-24.

[6] Rezai Rad M, Liu D, He H, et al. The role of dentin matrix protein 1 (DMP1) in regulation of osteogenic differentiation of rat dental follicle stem cells (DFSCs) [J]. Arch Oral Biol, 2015, 60(4):546-556.

[7] Wang G, Zhu Z, Lei C, et al. Low-dose risedronate sodium protects bone cells after abrupt oestrogen withdrawal[J]. J Int Med Res, 2012, 40(5):1761-1774.

[8] Li ZC, Jiang SD, Yan J, et al. Small-animal PET/CT assessment of bone microdamage in ovariectomized rats[J]. J Nucl Med, 2011, 52(5):769-775.

[9] Sharma D, Ciani C, Marin PA, et al. Alterations in the osteocyte lacunar-canalicular microenvironment due to estrogen deficiency[J]. Bone， 2012,51(3):488-497.

[10] Sun Y, Jiang Y, Liu Q, et al. Biomimetic engineering of nanofibrous gelatin scaffolds with noncollagenous proteins for enhanced bone regeneration[J]. Tissue Eng Part A， 2013,19(15-16):1754-1763.

[11] Verbruggen SW, Mc Garrigle MJ, Haugh MG, et al. Altered mechanical environment of bone cells in an animal model of short- and long-term osteoporosis[J]. Biophys J， 2015,108(7):1587-1598.

[12] Montagnani A. Bone anabolics in osteoporosis: Actuality and perspectives[J]. World J Orthop, 2014,5(3):247-254.

[13] Li CL, Lu WW, Seneviratne CJ, et al. Role of periodontal disease in bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats[J]. Clin Oral Implants Res, 2016, 27(1):1-6.

[14] Jilka RL, Noble B, Weinstein RS. Osteocyte apoptosis[J]. Bone, 2013, 54(2):264-271.

[15] Fukuda T, Takeda S, Xu R, et al. Sema3A regulates bone-mass accrual through sensory innervations[J]. Nature,2013, 497(7450):490-493.

[16] Boyce BF. Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts[J]. J Bone Miner Res, 2013, 28(4):711-722.

[17] Imai Y, Youn MY, Kondoh S, et al. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts[J]. Ann N Y Acad Sci, 2009, 1173 （Suppl 1）:E31-E39.

[18] Matsumoto T, Nagase Y, Iwasawa M, et al. Distinguishing the proapoptotic and antiresorptive functions of risedronate in murine osteoclasts: role of the Akt pathway and the ERK/Bim axis[J]. Arthritis Rheum, 2011, 63(12):3908-3917.

[19] Divieti Pajevic P. Recent progress in osteocyte research[J]. Endocrinol Metab (Seoul), 2013, 28(4):255-261.

[20] Gibson MP, Zhu Q, Wang S, et al. The rescue of dentin matrix protein 1 (DMP1)-deficient tooth defects by the transgenic expression of dentin sialophosphoprotein (DSPP) indicates that DSPP is a downstream effector molecule of DMP1 in dentinogenesis[J]. J Biol Chem, 2013, 288(10):7204-7214.

[21] Lin SX, Zhang Q, Zhang H, et al. Nucleus-targeted Dmp1 transgene fails to rescue dental defects in Dmp1 null mice[J]. Int J Oral Sci, 2014, 6(3):133-141.

[22] Fen JQ, Zhang J, Dallas SL, et al. Dentin matrix protein 1, atarget molecule for Cbfa1 in bone, is a unique bone marker gene[J]. J Bone Miner Res, 2002, 17(10):1822-1831.

[23] Rangiani A, Cao Z, Sun Y, et al. Protective roles of DMP1 in high phosphate homeostasis[J]. PLoS One, 2012, 7(8):e42329.

[24] Ye L, Zhang S, Ke H, et al. Periodontal breakdown in the Dmp1 null mouse model of hypophosphatemic rickets[J]. J Dent Res, 2008, 87(7):624-629.

[25] Feng JQ, Ward LM, Liu S, et al. Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism[J]. Nat Genet, 2006, 38(11):1310-1315.

[26] Gericke A, Qin C, Sun Y, et al. Different forms of DMP1 play distinct roles in mineralization[J]. J Dent Res, 2010, 89(4):355-359.

[27] Martin A, David V, Li H, et al. Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice[J]. Mol Endocrinol, 2012, 26(11):1883-1895.

[28] Sun Y, Gandhi V, Prasad M, et al. Distribution of small integrin-binding ligand, N-linked glycoproteins (SIBLING) in the condylar cartilage of rat mandible[J]. Int J Oral Maxillofac Surg， 2010,39(3):272-281.

[29] Qin C, D'Souza R, Feng JQ. Dentin matrix protein 1 (DMP1): new and important roles for biomineralization and phosphate homeostasis[J]. J Dent Res, 2007, 86(12):1134-1141.

[30] Lin S, Zhang Q, Cao Z, et al. Constitutive nuclear expression of dentin matrix protein 1 fails to rescue the Dmp1-null phenotype[J]. J Biol Chem, 2014, 289(31):21533-21543.

[31] Wu H, Teng PN, Jayaraman T, et al. Dentin matrix protein 1 (DMP1) signals via cell surface integrin[J]. J Biol Chem，2011,286(34):29462-29469.

[32] Narayanan K, Ramachandran A, Hao J, et al. Dual functional roles of dentin matrix protein 1. Implications in biomineralization and gene transcription by activation of intracellular Ca2+ store[J]. J Biol Chem, 2003, 278(19):17500-17508.

[33] Ravindran S, Narayanan K, Eapen AS, et al. Endoplasmic reticulum chaperone protein GRP-78 mediates endocytosis of dentin matrix protein 1[J]. J Biol Chem, 2008, 283(44):29658-29670.

[34] Siyam A, Wang S, Qin C, et al. Nuclear localization of DMP1 proteins suggests a role in intracellular signaling[J]. Biochem Biophys Res Commun, 2012, 424(3):641-646.

Please choose a citation manager

Content to export